000			01553 a2200457 4500
005			20250516053624.0
264		0	_c20111207
008			201112s 0 0 eng d
022			_a1095-6859
024	7		_a10.1016/j.ygyno.2011.07.034 _2doi
040			_aNLM _beng _cNLM
100	1		_aCoticchia, Christine M
245	0	0	_aUrinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. _h[electronic resource]
260			_bGynecologic oncology _cNov 2011
300			_a295-300 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute-Phase Proteins _xurine
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aArea Under Curve
650	0	4	_aBiomarkers, Tumor _xurine
650	0	4	_aCA-125 Antigen _xblood
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLipocalin-2
650	0	4	_aLipocalins _xurine
650	0	4	_aMatrix Metalloproteinase 2 _xurine
650	0	4	_aMatrix Metalloproteinase 9 _xurine
650	0	4	_aMiddle Aged
650	0	4	_aOvarian Neoplasms _xdiagnosis
650	0	4	_aProto-Oncogene Proteins _xurine
700	1		_aCuratolo, Adam S
700	1		_aZurakowski, David
700	1		_aYang, Jiang
700	1		_aDaniels, Kathryn E
700	1		_aMatulonis, Ursula A
700	1		_aMoses, Marsha A
773	0		_tGynecologic oncology _gvol. 123 _gno. 2 _gp. 295-300
856	4	0	_uhttps://doi.org/10.1016/j.ygyno.2011.07.034 _zAvailable from publisher's website
999			_c21130846 _d21130846